Gencurix Inc. (229000.KQ)

KRW 1446.0

(-0.69%)

Operating Income Summary of Gencurix Inc.

Gencurix Inc.'s latest annual operating income in 2023 was -12.37 Billion KRW , down -8.27% from previous year.
Gencurix Inc.'s latest quarterly operating income in 2024 Q2 was -2.99 Billion KRW , up 8.13% from previous quarter.
Gencurix Inc. reported an annual operating income of -11.43 Billion KRW in 2022, up 10.3% from previous year.
Gencurix Inc. reported an annual operating income of -12.74 Billion KRW in 2021, down -37.49% from previous year.
Gencurix Inc. reported a quarterly operating income of -2.99 Billion KRW for 2024 Q2, up 8.13% from previous quarter.
Gencurix Inc. reported a quarterly operating income of -3.17 Billion KRW for 2023 Q1, up 6.84% from previous quarter.

Annual Operating Income Chart of Gencurix Inc. (2023 - 2015)

Historical Annual Operating Income of Gencurix Inc. (2023 - 2015)

Year	Operating Income	Operating Income Growth
2023	-12.37 Billion KRW	-8.27%
2022	-11.43 Billion KRW	10.3%
2021	-12.74 Billion KRW	-37.49%
2020	-9.26 Billion KRW	-41.27%
2019	-6.56 Billion KRW	-14.87%
2018	-5.71 Billion KRW	9.74%
2017	-6.32 Billion KRW	22.43%
2016	-8.15 Billion KRW	-113.06%
2015	-3.82 Billion KRW	0.0%

Year	Operating Income	Operating Income Growth
2024 Q1	-3.02 Billion KRW	2.35%
2024 Q2	-2.99 Billion KRW	8.13%
2023 Q1	-3.17 Billion KRW	6.84%
2023 Q3	-2.55 Billion KRW	28.05%
2023 Q4	-3.09 Billion KRW	-21.39%
2023 Q2	-3.54 Billion KRW	-11.87%
2023 FY	-12.37 Billion KRW	-8.27%
2022 Q2	-3.16 Billion KRW	-45.68%
2022 FY	-11.43 Billion KRW	10.3%
2022 Q4	-3.4 Billion KRW	-26.67%
2022 Q3	-2.68 Billion KRW	15.01%
2022 Q1	-2.17 Billion KRW	62.07%
2021 FY	-12.74 Billion KRW	-37.49%
2021 Q2	-2.92 Billion KRW	-51.43%
2021 Q3	-2.16 Billion KRW	25.88%
2021 Q4	-5.72 Billion KRW	-164.32%
2021 Q1	-1.93 Billion KRW	57.49%
2020 Q1	-1.49 Billion KRW	33.06%
2020 FY	-9.26 Billion KRW	-41.27%
2020 Q4	-4.54 Billion KRW	-173.26%
2020 Q3	-1.66 Billion KRW	-6.09%
2020 Q2	-1.56 Billion KRW	-4.51%
2019 FY	-6.56 Billion KRW	-14.87%
2019 Q4	-2.23 Billion KRW	-44.33%
2019 Q3	-1.55 Billion KRW	0.0%
2018 FY	-5.71 Billion KRW	9.74%
2017 FY	-6.32 Billion KRW	22.43%
2016 FY	-8.15 Billion KRW	-113.06%
2015 FY	-3.82 Billion KRW	0.0%

Peer Operating Income Comparison of Gencurix Inc.

Name	Operating Income	Operating Income Difference
Osang Healthcare Co.,Ltd	142.82 Billion KRW	108.665%
InBody Co.,Ltd	44.46 Billion KRW	127.831%
Curexo Inc.	1.13 Billion KRW	1189.97%
Seegene, Inc.	-30 Billion KRW	58.759%
i-SENS, Inc.	10.92 Billion KRW	213.235%
Ray Co., Ltd.	6.11 Billion KRW	302.276%
Sugentech Inc.	-22.74 Billion KRW	45.581%
L&C Bio Co., Ltd	6.66 Billion KRW	285.635%